Text size
Berkshire Hathaway disclosed the fourth quarter purchases of Merck, Bristol-Myers and AbbVie, upon exiting Pfizer.
fake images
Berkshire Hathaway by Warren Buffett
recently made significant changes to its portfolio, in addition to buying
Verizon Communications
Y
Chevron,
and selling something
Apple
Values.
In the fourth quarter, Berkshire (ticker:
BRK.B
) added to positions in
Merck
(MRK),
Bristol-Myers Squibb
(BMY) and
AbbVie
(ABBV) and abandoned an investment in
Pfizer
(PFE). Buffett’s firm also continued to cut
Wells fargo
(WFC) and sold all its
PNC Financial Services
(PNC) actions. Elsewhere, Berkshire bought more
Kroger
(KR) and cut its investment in
General motors
(GM).
Buffett’s firm disclosed the stock transactions, among others, in a form it filed with the Securities and Exchange Commission.
Berkshire Hathaway did not immediately respond to a request for comment on the investment changes.
The firm increased its investments in Merck, Bristol-Myers and AbbVie by 28.1% to 28.7 million shares, 11.2% to 33.3 million shares and 20% to 25.5 million shares. , respectively. Berkshire Hathaway sold all of the 3.7 million shares of Pfizer in the fourth quarter that it had owned at the end of the third.
Berkshire Hathaway cut its stake in Wells Fargo by 59% to 52.4 million shares and sold the 1.9 million PNC shares it owned.
Buffett’s firm increased its stake in the Kroger grocery store by 34.3%, ending 2020 with 33.5 million shares. Berkshire reduced its stake in GM by 9.4% to 72.5 million shares.
Inside Scoop is a regular feature of Barron’s that covers the stock transactions of corporate executives and board members (so-called insiders), as well as large shareholders, politicians and other prominent figures. Due to their insider status, these investors are required to disclose stock transactions with the Securities and Exchange Commission or other regulatory groups..
Write to Ed lin at [email protected] and follow @BarronsEdLin.